Health CanadaGeneral Alert
Important Safety Information on the Association of Zevalin (ibritumomab tiuxetan...
Published: December 7, 2005Recall ID: 24135Category: generalCountry: Canada
Product Description & Identification
Important Safety Information on the Association of Zevalin (ibritumomab tiuxetan) with severe mucocutaneous reactions- Notice to Hospitals- Berlex Canada Inc.
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24135 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/important-safety-information-association-zevalin-ibritumomab-tiuxetan-severe |
| Title | Important Safety Information on the Association of Zevalin (ibritumomab tiuxetan) with severe mucocutaneous reactions- Notice to Hospitals- Berlex Canada Inc. |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2005-12-07 |
| Organization | Marketed health products |